This list is an analysis based on recent market events. It's not an investment recommendation.
About
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
What is Kobayashi Pharmaceutical stock price today?▼
The current price of KOY.STU is €39.60 EUR — it has increased by +4.76% in the past 24 hours. Watch Kobayashi Pharmaceutical stock price performance more closely on the chart.
What is Kobayashi Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Kobayashi Pharmaceutical stocks are traded under the ticker KOY.STU.
What is Kobayashi Pharmaceutical market cap?▼
Today Kobayashi Pharmaceutical has the market capitalization of 3.09B
When is the next Kobayashi Pharmaceutical earnings date?▼
Kobayashi Pharmaceutical is going to release the next earnings report on November 10, 2026.
What were Kobayashi Pharmaceutical earnings last quarter?▼
KOY.STU earnings for the last quarter are 0.01 EUR per share, whereas the estimation was 0.13 EUR resulting in a -94.47% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Kobayashi Pharmaceutical revenue for the last year?▼
Kobayashi Pharmaceutical revenue for the last year amounts to 941.36M EUR.
What is Kobayashi Pharmaceutical net income for the last year?▼
KOY.STU net income for the last year is 21.77M EUR.
Does Kobayashi Pharmaceutical pay dividends?▼
Yes, KOY.STU dividends are paid semi-annual. The last dividend per share was 0.25 . As of today, Dividend Yield (FWD)% is 1.5%.
How many employees does Kobayashi Pharmaceutical have?▼
As of November 7, 2026, the company has 3,731 employees.
In which sector is Kobayashi Pharmaceutical located?▼
Kobayashi Pharmaceutical operates in the Essentials sector.
When did Kobayashi Pharmaceutical complete a stock split?▼
The last stock split for Kobayashi Pharmaceutical was on June 28, 2016 with a ratio of 2:1.
Where is Kobayashi Pharmaceutical headquartered?▼
Kobayashi Pharmaceutical is headquartered in Osaka, Japan.